David Delaney insider trades: Pasithea Therapeutics (KTTA) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 17, 2022 | KTTA | ↑ Buy | 1,000 | $1.11 | $1K | Indirect | Oct 19, 2022 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other KTTA insiders
Open-market trades in the last 12 months
About David Delaney's insider trades
David Delaney is an insider at Pasithea Therapeutics (KTTA). Since Oct 17, 2022, David has reported 1 open-market purchase worth $1K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KTTA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.